OMS906 study drug — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 4mo
ESTIMATED |
READOUT
Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal He
Phase 2 · Paroxysmal Nocturnal Hemoglobinuria |
OMER OMEROS CORP | OMS906 study drug |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|